DAMANTI, SARAH
 Distribuzione geografica
Continente #
AS - Asia 3.540
NA - Nord America 2.363
EU - Europa 1.516
SA - Sud America 724
AF - Africa 93
OC - Oceania 48
Totale 8.284
Nazione #
US - Stati Uniti d'America 2.192
SG - Singapore 1.689
CN - Cina 849
BR - Brasile 633
IT - Italia 506
HK - Hong Kong 468
DE - Germania 258
VN - Vietnam 172
GB - Regno Unito 142
CA - Canada 99
FI - Finlandia 79
IN - India 79
NL - Olanda 79
RU - Federazione Russa 75
SE - Svezia 64
AT - Austria 62
MX - Messico 60
PL - Polonia 60
FR - Francia 56
AU - Australia 47
ES - Italia 46
AR - Argentina 41
JP - Giappone 37
BD - Bangladesh 36
ZA - Sudafrica 35
TR - Turchia 28
LT - Lituania 23
ID - Indonesia 20
TW - Taiwan 19
IE - Irlanda 18
IQ - Iraq 18
IR - Iran 16
BE - Belgio 13
EG - Egitto 11
PH - Filippine 11
PK - Pakistan 11
CO - Colombia 10
EC - Ecuador 10
UZ - Uzbekistan 10
VE - Venezuela 9
KR - Corea 8
MA - Marocco 8
SA - Arabia Saudita 8
TN - Tunisia 8
PY - Paraguay 7
BG - Bulgaria 6
IL - Israele 6
JO - Giordania 6
PE - Perù 6
AE - Emirati Arabi Uniti 5
BW - Botswana 5
CH - Svizzera 5
ET - Etiopia 5
AZ - Azerbaigian 4
KE - Kenya 4
LA - Repubblica Popolare Democratica del Laos 4
LB - Libano 4
MY - Malesia 4
PT - Portogallo 4
RO - Romania 4
TH - Thailandia 4
UA - Ucraina 4
BA - Bosnia-Erzegovina 3
CL - Cile 3
CR - Costa Rica 3
CY - Cipro 3
DZ - Algeria 3
KZ - Kazakistan 3
NG - Nigeria 3
PS - Palestinian Territory 3
RS - Serbia 3
SC - Seychelles 3
TT - Trinidad e Tobago 3
UY - Uruguay 3
BB - Barbados 2
BO - Bolivia 2
GD - Grenada 2
GR - Grecia 2
HR - Croazia 2
KH - Cambogia 2
NP - Nepal 2
OM - Oman 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TZ - Tanzania 2
AM - Armenia 1
AO - Angola 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CZ - Repubblica Ceca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
KG - Kirghizistan 1
MN - Mongolia 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TJ - Tagikistan 1
TL - Timor Orientale 1
Totale 8.283
Città #
Singapore 925
Dallas 640
Hong Kong 457
Ashburn 308
Hefei 180
Beijing 171
Shanghai 171
Milan 131
Los Angeles 111
New York 110
Munich 94
Nuremberg 76
Boardman 73
São Paulo 68
Ho Chi Minh City 57
Warsaw 48
Hanoi 43
Turku 39
Montreal 38
Vienna 36
Helsinki 35
Brooklyn 34
Denver 34
Rome 33
Santa Clara 33
Tokyo 33
Chennai 32
Orem 32
Frankfurt am Main 29
Poplar 29
Amsterdam 27
Johannesburg 26
London 26
Mexico City 24
Atlanta 23
Chicago 23
Falkenstein 22
Boston 21
Manchester 21
Moscow 21
Stockholm 20
Washington 19
Dublin 18
Genoa 18
Rio de Janeiro 18
Toronto 18
Houston 17
Guangzhou 16
San Francisco 16
Belo Horizonte 15
The Dalles 15
Ottawa 14
Phoenix 14
Ankara 13
Brussels 12
Florence 12
Querétaro 12
Bengaluru 11
Brasília 11
Melbourne 11
Mumbai 11
Sydney 11
León 10
Tianjin 10
Wollongong 10
Madrid 9
San Jose 9
Assago 8
Brisbane 8
Groningen 8
Lawrence 8
Miami 8
Naples 8
Princeton 8
Seattle 8
Calgary 7
Campinas 7
Caruaru 7
Charlotte 7
City of London 7
Monza 7
Tashkent 7
Verona 7
Wroclaw 7
Amman 6
Cairo 6
Can Tho 6
Curitiba 6
Fortaleza 6
Gatchina 6
Guarulhos 6
Haiphong 6
Hải Dương 6
Rho 6
Shenzhen 6
Turin 6
Annapolis 5
Baghdad 5
Biên Hòa 5
Bogotá 5
Totale 4.923
Nome #
Biomarkers for Sarcopenia: Predicting Muscle Mass and Function Decline Through GDF-15, FGF21, sRAGE, and Neurofilaments 334
The Banality of Evil: Error Frequency in Therapy Assumption Without Medical Reconciliation: a Case Report 193
Molecular constraints of sarcopenia in the ageing muscle 181
Outcomes of non-invasive ventilation as the ceiling of treatment in patients with COVID-19 180
A Nomogram-Based Model to Predict Respiratory Dysfunction at 6 Months in Non-Critical COVID-19 Survivors 102
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 95
Multimorbidity and polypharmacy in the elderly: Lessons from REPOSI 90
Continuous positive airway pressure and pronation outside the Intensive Care Unit in COVID-19 acute respiratory distress syndrome 81
Prevalence of potentially inappropriate medications and risk of adverse clinical outcome in a cohort of hospitalized elderly patients: results from the REPOSI Study 79
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 77
HMGB1, an evolving pleiotropic protein critical for cellular and tissue homeostasis: role in aging and age-related diseases 77
Evolving Clinical Manifestations and Symptom Clusters in Long-COVID Patients: a Comparative Analysis from April 2020 to Present 76
Biomarkers per la sarcopenia: come prevenire il declino della massa e della funzione muscolare 76
Fat mass predicts frailty and sarcopenia: prospective data from the FRASNET study 75
LENGTH OF STAY IN INTERNAL MEDICINE: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 75
Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors 72
One-year mental health outcomes in a cohort of COVID-19 survivors 72
Prevalence of Long COVID-19 Symptoms After Hospital Discharge in Frail and Robust Patients 70
Association between frailty-related genetic polymorphisms and obesity in older adults: insights from the FRASNET study 70
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 69
Does the Right Focal Variant of Alzheimer's Disease Really Exist? A Literature Analysis 69
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 68
A continuity care program in chronic, complex and frail patients: the PRO-CCF study protocol 67
HOSPITALIZATION COURSE AND OUTCOMES OF CANCER PATIENTS ADMITTED TO INTERNAL MEDICINE UNITS: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 67
Frailty as a predictor of mortality in COVID-19 patients receiving CPAP for respiratory insufficiency 65
Sarcopenic obesity and pre-sarcopenia contribute to frailty in community-dwelling Italian older people: data from the FRASNET study 64
Exploring the Association between Delirium and Malnutrition in COVID-19 Survivors: A Geriatric Perspective 64
Influence of reduced muscle mass and quality on ventilator weaning and complications during intensive care unit stay in COVID-19 patients 63
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 62
EARLY RECOGNITION AND PROMPT TREATMENT OF ACUTE SARCOPENIA: IMPACT ON SHORT- AND LONG-TERM OUTCOMES 61
Cognitive status in the oldest old and centenarians : a condition crucial for quality of life methodologically difficult to assess 61
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS (DRESS) PRESENTING WITH THYROID DYSFUNCTION: A CASE REPORT 61
REAL WORLD EXPERIENCE AND CURRENT LITERATURE: HOW TO DESIGN A LONG-COVID CLINIC 60
Muscle quality assessment in COVID-19 survivors: agreement between echointensity and stiffness 60
A CASE REPORT OF DIFFICULT DIFFERENTIAL DIAGNOSIS IN UNCOMMON CLINICAL ONSET OF SYSTEMIC LUPUS ERYTHEMATOSUS 59
A thrombotic storm 58
Frailty index, frailty phenotype and 6-year mortality trends in the FRASNET cohort 58
INTRODUCING A NOVEL HOSPITAL-TO-HOME CARE PROGRAMME IN CHRONIC/COMPLEX/FRAIL PATIENTS: THE PRO-CCF STUDY 57
Six-month respiratory outcomes and exercise capacity of COVID-19 acute respiratory failure patients treated with continuous positive airway pressure 55
IMPACT OF POST-COVID-19 OUTPATIENT CLINIC ON PATIENTS’ QUALITY OF LIFE AND POSTHOSPITALIZATION MORTALITY 54
Acute Sarcopenia: Mechanisms and Management 54
SARCOPENIA 54
UNINTENTIONAL WEIGHT LOSS IN COVID-19 SURVIVORS FROM THE FIRST AND THE SECOND PANDEMIC WAVES 54
INTRODUCING SUSTAINABILITY IN MEDICINE:THE SIM STUDY 54
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 53
Development and validation of an algorithm to classify the level of cognitive impairment based on voice features: Study within the MoveCare project: Multiple virtual actors empathic caregiver for the Old (732 158 - MoveCare - H2020-TIC-2016- 2017 / H2020-ICT-2016-1) 53
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 53
Adapted physical activity to promote active and healthy ageing : the PoliFIT pilot randomized waiting list-controlled trial 53
Appropriateness of antiplatelet therapy for primary and secondary cardio‐ and cerebrovascular prevention in acutely hospitalized older people 52
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly 51
Need for deprescribing in hospital elderly patients discharged with a limited life expectancy: The REPOSI study 51
LONG COVID-19 AFTER HOSPITAL DISCHARGE IN FRAIL AND ROBUST PATIENTS 51
Sustainability in Internal Medicine: A Year-Long Ward-Wide Observational Study 51
Orthostatic hypotension, an often-neglected problem in community-dwelling older people: discrepancies between studies and real life 51
Transcriptional and epigenetic phenomena in peripheral blood cells of monozygotic twins discordant for Alzheimer’s disease, a case report 51
MACROPHAGE ACTIVATION SYNDROME IN EARLY SYSTEMIC LUPUS ERYTHEMATOSUS: A CLINICAL CASE REPORT 51
Evaluation of Muscle Mass and Stiffness with Limb Ultrasound in COVID-19 Survivors 51
DIFFERENTIAL PROFILES OF BACTEREMIA IN EMERGENCY AND MEDICINE DEPARTMENTS: PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 51
A cascade of complications in a hospitalized frail older patient: is a better management possible? 50
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 50
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 50
A case of right Alzheimer’s disease 50
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study 49
Under-detection of delirium and impact of neurocognitive deficits on in-hospital mortality among acute geriatric and medical wards 49
Agreement Between Potential Drug Interactions Identified by an Electronic Tooland Clinical Judgment: INTERcheck® versus Physicians 49
A CASE OF PRIMARY ADRENAL EBV+ EXTRANODAL NK/T-CELL LYMPHOMA 48
PALMITOYLETHANOLAMIDE (PEA) IN PERSISTENT DEPRESSION, CHRONIC PAIN AND FATIGUE IN PATIENTS RECOVERED FROM COVID-19 48
EFFICACY AND SAFETY OF CONTINUOUS POSITIVE AIRWAY PRESSURE AND PATIENT MOBILIZATION FOR ARDS DUE TO COVID-19 IN A NON-ICU SETTING 48
Dyspnea as a symptom of progressive chronic myeloproliferative disease: a rare case of hemorrhagic alveolitis and pulmonary fibrosis, due to extramedullary erythropoiesis 46
Alzheimer's Disease Diagnosis: Discrepancy between Clinical, Neuroimaging, and Cerebrospinal Fluid Biomarkers Criteria in an Italian Cohort of Geriatric Outpatients: A Retrospective Cross-sectional Study 46
Antipsychotic prescription and mortality in hospitalized older persons 46
Biomarkers of aging in frailty and age-associated disorders: State of the art and future perspective 46
Prevalence, characteristics and treatment of chronic pain in elderly patients hospitalized in internal medicine wards 46
NONBACTERIAL THROMBOTIC ENDOCARDITIS AND DIFFUSED INTRAVASCULAR COAGULATION IN RAPIDLY PROGRESSING PROSTATIC ADENOCARCINOMA: A CLINICAL CASE 46
PYODERMA GANGRENOSUM REVEALING TAKAYASU ARTERITIS IN A 65-YEAR-OLD CAUCASIAN WOMAN: A CASE REPORT 45
HEALTH STATUS OF COVID-19 SURVIVORS: A COMPARISON BETWEEN THE FIRST AND THE SECOND PANDEMIC WAVE 45
Pattern of in‐hospital changes in drug use in the older people from 2010 to 2016 44
Disability, and not diabetes, is a strong predictor of mortality in oldest old patients hospitalized with pneumonia 44
The association between CKD and frailty in the FRASNET study: suggestion of a novel eGFR threshold as a key determinant of frailty in the elderly 44
An insight into the mechanisms underlying the sympathoinhibition of acromegaly 43
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 43
PROMISING INNOVATIVE BIOMARKERS FOR FRAILTY AND SARCOPENIA: DATA FROM THE FRASNET STUDY 43
EVIDENCE OF REDUCED MUSCLE MASS NOT ALWAYS ASSOCIATED WITH REDUCED MUSCLE STRENGTH IN POST COVID-19 PATIENTS: is this picture indicative of a recovery from acute sarcopenia 43
NEW-ONSET HYPERGLYCAEMIA IN NON DIABETIC PATIENTS DURING SARS-COV-2 HOSPITALIZATION: PREVALENCE AND RISK FACTORS 43
WHIPPLE’S BACKLASH: IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME. A CASE REPORT 42
Gender-differences in disease distribution and outcome in hospitalized elderly : Data from the REPOSI study 42
Muscle function and waist circumference predict frailty in Italian older individuals: assessing concordance among various frailty definitions in the FRASNET Study 42
Automatic speech analysis to early detect functional cognitive decline in elderly population 42
Anemia in the elderly : evaluation in consecutive patients admitted to an Internal Medicine Unit 42
Pain and Frailty in Hospitalized Older Adults 41
BEHEADED MENINGITIS: A CASE REPORT 41
A challenging case of pelvic inflammatory disease due to miliary tuberculosis 41
Selective serotonin reuptake inhibitors and fractures in older nursing home residents: Data from the INCUR study 40
DISCORDANT DIAGNOSIS OF PULMONARY LYMPHOMATOID GRANULOMATOSIS AND EBVNEGATIVE DIFFUSE LARGE B-CELL LYMPHOMA IN THE SAME PATIENT, A CASE REPORT 40
Atrial Fibrillation: Possible Influences of Rate and Rhythm Control Strategy on Cognitive Performance 40
Statins, ACE/ARBs drug use, and risk of pneumonia in hospitalized older patients: a retrospective cohort study 40
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 39
ANISOCORIA LEADING TO THE CAUSE OF COGNITIVE DECLINE: A CASE REPORT 39
SECOND AND THIRD LINE ANTIMICROBIAL THERAPY IN INTERNAL MEDICINE DEPARTMENTS: A PROSPECTIVE ANALYSIS ON PRELIMINARY DATA FROM A MULTIPURPOSE HOSPITAL REGISTRY 39
RUOLO DELLE ALTERAZIONI METABOLICHE NELLA DEMENZA FRONTO-TEMPORALE 39
Totale 6.169
Categoria #
all - tutte 37.517
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.517


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212 0 0 0 0 0 2 0 0 0 0 0 0
2021/202215 0 0 0 1 0 3 3 0 2 0 2 4
2022/202396 20 16 7 6 11 8 6 9 2 1 5 5
2023/2024290 11 10 18 10 14 20 5 10 0 21 112 59
2024/20253.186 150 23 27 222 186 232 546 245 412 291 369 483
2025/20264.981 782 830 784 1.281 952 352 0 0 0 0 0 0
Totale 8.570